Logo image of NXXT

NEXTNRG INC (NXXT) Stock Fundamental Analysis

USA - NASDAQ:NXXT - US6529411059 - Common Stock

2.75 USD
-0.07 (-2.48%)
Last: 10/8/2025, 8:04:57 PM
2.68 USD
-0.07 (-2.55%)
Pre-Market: 10/9/2025, 7:28:22 AM
Fundamental Rating

2

Taking everything into account, NXXT scores 2 out of 10 in our fundamental rating. NXXT was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. NXXT may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, NXXT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NXXT had negative earnings in the past year.
NXXT had a negative operating cash flow in the past year.
In the past 5 years NXXT always reported negative net income.
In the past 5 years NXXT always reported negative operating cash flow.
NXXT Yearly Net Income VS EBIT VS OCF VS FCFNXXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

The Return On Assets of NXXT (-221.07%) is worse than 98.58% of its industry peers.
Industry RankSector Rank
ROA -221.07%
ROE N/A
ROIC N/A
ROA(3y)-161.15%
ROA(5y)-156.47%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NXXT Yearly ROA, ROE, ROICNXXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 -600

1.3 Margins

Looking at the Gross Margin, with a value of 6.80%, NXXT is doing worse than 72.51% of the companies in the same industry.
NXXT's Gross Margin has improved in the last couple of years.
NXXT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y41.86%
GM growth 5Y2.37%
NXXT Yearly Profit, Operating, Gross MarginsNXXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

1

2. Health

2.1 Basic Checks

NXXT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NXXT has been increased compared to 1 year ago.
Compared to 5 years ago, NXXT has less shares outstanding
Compared to 1 year ago, NXXT has an improved debt to assets ratio.
NXXT Yearly Shares OutstandingNXXT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NXXT Yearly Total Debt VS Total AssetsNXXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -5.65, we must say that NXXT is in the distress zone and has some risk of bankruptcy.
NXXT's Altman-Z score of -5.65 is on the low side compared to the rest of the industry. NXXT is outperformed by 77.25% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.65
ROIC/WACCN/A
WACC8.65%
NXXT Yearly LT Debt VS Equity VS FCFNXXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

NXXT has a Current Ratio of 0.22. This is a bad value and indicates that NXXT is not financially healthy enough and could expect problems in meeting its short term obligations.
NXXT has a Current ratio of 0.22. This is amonst the worse of the industry: NXXT underperforms 94.79% of its industry peers.
A Quick Ratio of 0.21 indicates that NXXT may have some problems paying its short term obligations.
The Quick ratio of NXXT (0.21) is worse than 94.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.21
NXXT Yearly Current Assets VS Current LiabilitesNXXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

6

3. Growth

3.1 Past

NXXT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.43%, which is quite good.
NXXT shows a strong growth in Revenue. In the last year, the Revenue has grown by 53.34%.
NXXT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 86.83% yearly.
EPS 1Y (TTM)15.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.16%
Revenue 1Y (TTM)53.34%
Revenue growth 3Y56.61%
Revenue growth 5Y86.83%
Sales Q2Q%40.74%

3.2 Future

NXXT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -31.91% yearly.
Based on estimates for the next years, NXXT will show a very strong growth in Revenue. The Revenue will grow by 26.15% on average per year.
EPS Next Y-179.55%
EPS Next 2Y-53.74%
EPS Next 3Y-31.91%
EPS Next 5YN/A
Revenue Next Year37.29%
Revenue Next 2Y33.03%
Revenue Next 3Y26.15%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NXXT Yearly Revenue VS EstimatesNXXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
NXXT Yearly EPS VS EstimatesNXXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NXXT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NXXT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXXT Price Earnings VS Forward Price EarningsNXXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXXT Per share dataNXXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

A cheap valuation may be justified as NXXT's earnings are expected to decrease with -31.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-53.74%
EPS Next 3Y-31.91%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NXXT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEXTNRG INC

NASDAQ:NXXT (10/8/2025, 8:04:57 PM)

Premarket: 2.68 -0.07 (-2.55%)

2.75

-0.07 (-2.48%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-14 2025-08-14
Earnings (Next)11-12 2025-11-12
Inst Owners1.6%
Inst Owner Change0%
Ins Owners60.75%
Ins Owner Change2.11%
Market Cap345.32M
Analysts82.5
Price Target5.61 (104%)
Short Float %0.78%
Short Ratio0.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.33%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-66.67%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.64%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.94
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.33
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.4
BVpS-0.11
TBVpS-0.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -221.07%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.8%
FCFM N/A
ROA(3y)-161.15%
ROA(5y)-156.47%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y41.86%
GM growth 5Y2.37%
F-Score4
Asset Turnover1.95
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.21
Altman-Z -5.65
F-Score4
WACC8.65%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.16%
EPS Next Y-179.55%
EPS Next 2Y-53.74%
EPS Next 3Y-31.91%
EPS Next 5YN/A
Revenue 1Y (TTM)53.34%
Revenue growth 3Y56.61%
Revenue growth 5Y86.83%
Sales Q2Q%40.74%
Revenue Next Year37.29%
Revenue Next 2Y33.03%
Revenue Next 3Y26.15%
Revenue Next 5YN/A
EBIT growth 1Y-383.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-44.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.8%
OCF growth 3YN/A
OCF growth 5YN/A